Why the study?
Prevention of stroke is of primary importance, leading to the development of left atrial appendage occlusion for selected patients with non-valvular atrial fibrillation.
Population
Selected patients with non-valvular atrial fibrillation
Design
Review
Answers are grounded in this paper and cite their sources.
LAAO expands stroke prevention options beyond OAC and PFO closure; leaves open optimal patient selection and comparative effectiveness.
Prevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous revascularisation in patients with carotid disease, device closure for patients with patent foramen ovale, and now, left atrial appendage occlusion (LAAO) for selected patients with non-valvular atrial fibrillation (NVAF). The latter group of patients are the focus of this review which evaluates the pathophysiology, selection of patients, procedural performance, outcomes of treatment both during and post-procedure, adjunctive therapy, complications, and longer-term outcomes.
No takes yet. Share an insight, caveat, or question.
Holmes et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: